Grant of Options and Warrants
04/04/2023 17:12
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230404:nRSD3744Va&default-theme=true
RNS Number : 3744V Cellular Goods PLC 04 April 2023
The information contained within this announcement is deemed by the Company to
constitute inside information stipulated under the Market Abuse Regulation
(EU) No. 596/2014, as retained as part of the law of England and Wales. Upon
the publication of this announcement via the Regulatory Information Service,
this inside information is now considered to be in the public domain.
Press release
4 April 2023
Cellular Goods PLC
("Cellular Goods" or "the Company")
Grant of Options and Warrants
Cellular Goods (LSE: CBX) a UK-based skincare and wellness company providing
premium consumer products formulated with lab-produced cannabinoids, announces
that it has granted certain options and warrants in accordance with the terms
agreed with each of Bruna Nikolla, the Company's Chief Financial Officer, and
Gill Whitty-Collins, a non-executive director of the Company, in connection
with their respective appointments.
Bruna Nikolla has been granted options over 7,000,000 ordinary shares of
£0.001 each in the Company ("Ordinary Shares") at an exercise price of 1.2
pence per Ordinary Share. Gill Whitty Collins has been granted a warrant over
2,000,000 Ordinary Shares at an exercise price of 2.9 pence per Ordinary
Share. The exercise prices reflect the prevailing share price at the date of
their respective engagements with the Company. One third of the options and
warrants (respectively) vest on the first anniversary of their respective
engagement with the Company, with the remaining shares vesting in 24 equal
monthly instalments thereafter.
For further information please contact:
Cellular Goods
Darcy Taylor Via Tancredi +44 207 887 7633
Chairman and interim CEO
Neil Thapar +44 787 645 5323
Investor Relations
Tennyson Securities
Corporate Broker & Adviser
Peter Krens +44 207 186 9030
Alan Howard
Novum Securities
Corporate Broker
Colin Rowbury
Jon Belliss +44 207 399 9427
Tancredi Intelligent Communication
Media Relations
Helen Humphrey +44 744 922 6720
Charlie Hobbs +44 789 755 7112
cellulargoods@tancredigroup.com
About Cellular Goods PLC:
Cellular Goods is a UK-based wellness company that provides premium products
based on lab-made cannabinoids. It was established in August 2018 to develop
efficacy-led and research-backed cannabinoid-powered wellness products. The
initial focus is on three product verticals: Feel Better, Look Better and
Function Better. These three verticals encompass Cellular Goods' premium CBG
skincare and CBD wellness with the first products launched in December 2021.
The Company's shares are listed on the main market of the London Stock
Exchange. www.cellular-goods.com (http://www.cellular-goods.com)
The following information relating to the transaction by a Director has been
filed with the Financial Conduct Authority in accordance with Article 19(1) of
UK MAR.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Bruna Nikolla
2 Reason for the notification
a) Position/status Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Cellular Goods PLC
b) LEI 213800IXPX4Z2MKX2U28
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.001 each
Identification code
ISIN: GB00BK964W87
b) Nature of the transaction Grant of options over 7,000,000 ordinary shares
c) Price(s) and volume(s) Price No. of shares
£0.012 7,000,000
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 28 March 2023
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A single transaction
e)
Date of the transaction
28 March 2023
f)
Place of the transaction
Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Gill Whitty-Collins
2 Reason for the notification
a) Position/status Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Cellular Goods PLC
b) LEI 213800IXPX4Z2MKX2U28
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.001 each
Identification code
ISIN: GB00BK964W87
b) Nature of the transaction Grant of warrant over 2,000,000 ordinary shares
c) Price(s) and volume(s) Price No. of shares
£0.029 2,000,000
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 3, April 2023
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A single transaction
e)
Date of the transaction
3, April 2023
f)
Place of the transaction
Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUPUQUCUPWGQC